Evolution of antigen-specific immune responses in cutaneous leishmaniasis patients.

Akram Miramin MohammadiMalcolm S DuthieSteven G ReedAmir Javadi Ali Khamesipour

Published in: Parasite immunology (2021)

Together, our results provide further insight into the development of immune responses during CL and further validate the selection of LEISH-F2 and LEISH-F3 as vaccine antigen candidates.

Keyphrases

immune response
end stage renal disease
newly diagnosed
chronic kidney disease
dendritic cells
peritoneal dialysis
toll like receptor
patient reported outcomes